Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation THT 2025

SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli

Presenter: Howard Herrmann

February 12, 2025

Presentation THT 2025

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation THT 2025

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

Presenter: Torsten Vahl

February 12, 2025

Presentation THT 2025

TTVI Trial Updates

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Presenter: Michael Brener

February 12, 2025

Presentation THT 2025

Putting It All Together: A Case of TTVR

Presenter: Karl-Philipp Rommel

February 12, 2025

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Presenter: Nicolas Van Mieghem

February 12, 2025

Presentation ESC 2024

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Presenter: Muthiah Vaduganathan

September 01, 2024

Presentation TCT 2023

Management of Aortic Regurgitation in LVAD Patients

Presenter: Lauren Ranard

October 24, 2023

Presentation TCT 2023

What Should the Interventionist Know About Aortic Regurgitation?

Presenter: Robert Bonow

October 24, 2023

Presentation TCT 2023

Moderate AS in HFrEF: Time to Treat Is Now

Presenter: Nicolas Van Mieghem

October 24, 2023

Presentation TCT 2023

Assessing the Risk of LV Failure After TAVR

Presenter: Sabah Skaf

October 24, 2023

Presentation TCT 2023

Atrial Secondary MR or TR in HFpEF: How to Treat

Presenter: Sanjiv Shah

October 24, 2023

Presentation TCT 2023

When Is It Too Late for Mitral-TEER?

Presenter: Jerry Estep

October 24, 2023

Presentation TCT 2023

The Role of RV and RV-PA Coupling in Outcomes Following AV-Valve Interventions

Presenter: Karl-Philipp Rommel

October 24, 2023

Presentation TCT 2023

Pillars of Heart Failure Management in Functional AV-Valve Disease

Presenter: Liviu Klein

October 24, 2023

Presentation Miami Valves 2023

Myocardial Disease in SCD -The Dynamic Nature of Risk

Presenter: Juhani Junttila

February 03, 2023

Presentation THT 2022

Implications of RVF in Structural Heart Procedures

Presenter: Rebecca Hahn

February 02, 2022

Advertisement

SMART Revisited: Contemporary Evidence for Treating AS in Patients With Small Annuli

Lessons From AVR Studies in Patients With Aortic Stenosis and Heart Failure

Case Presentation for the Heart Team: A Polyvalvular Conundrum With LF-LG AS and Severe MR

A Patient With HF and AR: How and When to Treat With TAVR and SAVR

TTVI Trial Updates

Strategies to Reduce the Burden of Residual MACE After mTEER in Patients With FMR

Putting It All Together: A Case of TTVR

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Cardiomechanics in Patients Undergoing mTEER: Insights From PV Analysis

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Management of Aortic Regurgitation in LVAD Patients

What Should the Interventionist Know About Aortic Regurgitation?

Moderate AS in HFrEF: Time to Treat Is Now

Assessing the Risk of LV Failure After TAVR

Atrial Secondary MR or TR in HFpEF: How to Treat

When Is It Too Late for Mitral-TEER?

The Role of RV and RV-PA Coupling in Outcomes Following AV-Valve Interventions

Pillars of Heart Failure Management in Functional AV-Valve Disease

Myocardial Disease in SCD -The Dynamic Nature of Risk

Implications of RVF in Structural Heart Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content